Cargando…
Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability
Up-regulation of the complement component 4A (C4A) in the brain has been associated with excessive synaptic pruning and increased schizophrenia (SZ) susceptibility. Over-expression of C4A has been observed in SZ postmortem brain tissue, and the gene encoding for a protein inhibitor of C4A activity,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508018/ https://www.ncbi.nlm.nih.gov/pubmed/35532796 http://dx.doi.org/10.1007/s00406-022-01409-5 |
_version_ | 1784796928648675328 |
---|---|
author | Hatzimanolis, Alex Foteli, Stefania Stefanatou, Pentagiotissa Ntigrintaki, Angeliki-Aikaterini Ralli, Irene Kollias, Konstantinos Nikolaou, Chrysoula Gazouli, Maria Stefanis, Nikos C. |
author_facet | Hatzimanolis, Alex Foteli, Stefania Stefanatou, Pentagiotissa Ntigrintaki, Angeliki-Aikaterini Ralli, Irene Kollias, Konstantinos Nikolaou, Chrysoula Gazouli, Maria Stefanis, Nikos C. |
author_sort | Hatzimanolis, Alex |
collection | PubMed |
description | Up-regulation of the complement component 4A (C4A) in the brain has been associated with excessive synaptic pruning and increased schizophrenia (SZ) susceptibility. Over-expression of C4A has been observed in SZ postmortem brain tissue, and the gene encoding for a protein inhibitor of C4A activity, CUB and Sushi multiple domains 1 (CSMD1) gene, has been implicated in SZ risk and cognitive ability. Herein, we examined C4A and CSMD1 mRNA expression in peripheral blood from antipsychotic-naive individuals with first-episode psychosis (FEP; n = 73) and mentally healthy volunteers (n = 48). Imputed C4 locus structural alleles and C4A serum protein levels were investigated. Associations with symptom severity and cognitive domains performance were explored. A significant decrease in CSMD1 expression levels was noted among FEP patients compared to healthy volunteers, further indicating a positive correlation between C4A and CSMD1 mRNA levels in healthy volunteers but not in FEP cases. In addition, C4 copy number variants previously associated with SZ risk correlated with higher C4A mRNA levels in FEP cases, which confirms the regulatory effect of C4 structural variants on gene expression. Evidence also emerged for markedly elevated C4A serum concentrations in FEP cases. Within the FEP patient group, higher C4A mRNA levels correlated with more severe general psychopathology symptoms and lower CSMD1 mRNA levels predicted worse working memory performance. Overall, these findings suggest C4A complement pathway perturbations in individuals with FEP and corroborate the involvement of CSMD1 in prefrontal-mediated cognitive functioning. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00406-022-01409-5. |
format | Online Article Text |
id | pubmed-9508018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-95080182022-09-25 Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability Hatzimanolis, Alex Foteli, Stefania Stefanatou, Pentagiotissa Ntigrintaki, Angeliki-Aikaterini Ralli, Irene Kollias, Konstantinos Nikolaou, Chrysoula Gazouli, Maria Stefanis, Nikos C. Eur Arch Psychiatry Clin Neurosci Original Paper Up-regulation of the complement component 4A (C4A) in the brain has been associated with excessive synaptic pruning and increased schizophrenia (SZ) susceptibility. Over-expression of C4A has been observed in SZ postmortem brain tissue, and the gene encoding for a protein inhibitor of C4A activity, CUB and Sushi multiple domains 1 (CSMD1) gene, has been implicated in SZ risk and cognitive ability. Herein, we examined C4A and CSMD1 mRNA expression in peripheral blood from antipsychotic-naive individuals with first-episode psychosis (FEP; n = 73) and mentally healthy volunteers (n = 48). Imputed C4 locus structural alleles and C4A serum protein levels were investigated. Associations with symptom severity and cognitive domains performance were explored. A significant decrease in CSMD1 expression levels was noted among FEP patients compared to healthy volunteers, further indicating a positive correlation between C4A and CSMD1 mRNA levels in healthy volunteers but not in FEP cases. In addition, C4 copy number variants previously associated with SZ risk correlated with higher C4A mRNA levels in FEP cases, which confirms the regulatory effect of C4 structural variants on gene expression. Evidence also emerged for markedly elevated C4A serum concentrations in FEP cases. Within the FEP patient group, higher C4A mRNA levels correlated with more severe general psychopathology symptoms and lower CSMD1 mRNA levels predicted worse working memory performance. Overall, these findings suggest C4A complement pathway perturbations in individuals with FEP and corroborate the involvement of CSMD1 in prefrontal-mediated cognitive functioning. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00406-022-01409-5. Springer Berlin Heidelberg 2022-05-09 2022 /pmc/articles/PMC9508018/ /pubmed/35532796 http://dx.doi.org/10.1007/s00406-022-01409-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Hatzimanolis, Alex Foteli, Stefania Stefanatou, Pentagiotissa Ntigrintaki, Angeliki-Aikaterini Ralli, Irene Kollias, Konstantinos Nikolaou, Chrysoula Gazouli, Maria Stefanis, Nikos C. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability |
title | Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability |
title_full | Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability |
title_fullStr | Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability |
title_full_unstemmed | Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability |
title_short | Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability |
title_sort | deregulation of complement components c4a and csmd1 peripheral expression in first-episode psychosis and links to cognitive ability |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508018/ https://www.ncbi.nlm.nih.gov/pubmed/35532796 http://dx.doi.org/10.1007/s00406-022-01409-5 |
work_keys_str_mv | AT hatzimanolisalex deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability AT fotelistefania deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability AT stefanatoupentagiotissa deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability AT ntigrintakiangelikiaikaterini deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability AT ralliirene deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability AT kolliaskonstantinos deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability AT nikolaouchrysoula deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability AT gazoulimaria deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability AT stefanisnikosc deregulationofcomplementcomponentsc4aandcsmd1peripheralexpressioninfirstepisodepsychosisandlinkstocognitiveability |